BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8756151)

  • 1. [Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast].
    Fischer U; Vosshenrich R; Kopka L; Kahlen O; Grabbe E
    Bildgebung; 1996 Jun; 63(2):94-100. PubMed ID: 8756151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamic contrast medium studies with flash sequences in nuclear magnetic resonance tomography of the breast].
    Heywang SH; Hilbertz T; Pruss E; Wolf A; Permanetter W; Eiermann W; Lissner J
    Digitale Bilddiagn; 1988 Mar; 8(1):7-13. PubMed ID: 3383539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative assessment of therapy related effects after breast conserving therapy with dynamic MRI of the breast].
    Wersebe A; Xydeas T; Clauss T; Dietz K; Belka C; Fersis N; Claussen CD; Müller-Schimpfle M
    Rofo; 2001 Dec; 173(12):1109-17. PubMed ID: 11740672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of the breast after surgery for breast cancer.
    Whitehouse GH; Moore NR
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):591-603. PubMed ID: 7489311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
    Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
    Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.
    Heywang-Köbrunner SH; Haustein J; Pohl C; Beck R; Lommatzsch B; Untch M; Nathrath WB
    Radiology; 1994 Jun; 191(3):639-46. PubMed ID: 8184040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid.
    Kaiser WA
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):539-55. PubMed ID: 7489307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
    Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
    Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography.
    Brinck U; Fischer U; Korabiowska M; Jutrowski M; Schauer A; Grabbe E
    AJR Am J Roentgenol; 1997 May; 168(5):1331-4. PubMed ID: 9129437
    [No Abstract]   [Full Text] [Related]  

  • 10. [MR imaging for breast cancer].
    Seki T; Hachiya J; Nitatori T; Yokoyama K; Fukushima H; Uchigasaki S
    Nihon Geka Gakkai Zasshi; 1996 May; 97(5):347-56. PubMed ID: 8709936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress.
    Pierce WB; Harms SE; Flamig DP; Griffey RH; Evans WP; Hagans JE
    Radiology; 1991 Dec; 181(3):757-63. PubMed ID: 1947093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MRI-controlled intervention in suspected lesions of the breast].
    Vosshenrich R; Fischer U; Grabbe E
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):173-6. PubMed ID: 8682281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery.
    Boné B; Aspelin P; Isberg B; Perbeck L; Veress B
    Acta Radiol; 1995 Mar; 36(2):111-6. PubMed ID: 7710787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative dynamic contrast breast-MRI with the 0.5 tesla equipment].
    Klengel S; Hietschold V; Schreiber M; Köhler K
    Rontgenpraxis; 1994 Aug; 47(8):223-8. PubMed ID: 7974011
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contrast media in MR mammography].
    Tontsch P; Bauer M; Birmelin G; von Landenberg E; Moeller TB; Raible G
    Aktuelle Radiol; 1997 Mar; 7(2):86-92. PubMed ID: 9172669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
    Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
    Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
    Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
    Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
    Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Masuda K; Toyoshima S; Kuroki S; Ohno S
    Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
    Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
    Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Technics for the preoperative marking of nonpalpable breast lesions in MRT].
    Sittek H; Kessler M; Müller-Lisse U; Untch M; Bohmert H; Reiser M
    Rofo; 1996 Jul; 165(1):84-7. PubMed ID: 8765369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.